VNP40101M Followed by Cytarabine in Treating Older Patients With Acute Myeloid Leukemia

NCT00354276 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

85

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukemia

Interventions

DRUG: cytarabine
DRUG: laromustine

Sponsor

Vion Pharmaceuticals